(Q55428226)

9 July 2018

title

[MiR-192 confers cisplatin resistance by targeting Bim in lung cancer]. (English)

1 reference

9 July 2018

author name string

Fang Zhang

1

1 reference

9 July 2018

Yang Li

2

1 reference

9 July 2018

Heng Wu

3

1 reference

9 July 2018

Kang Qi

4

1 reference

9 July 2018

Jiacong You

5

1 reference

9 July 2018

Xuebing Li

6

1 reference

9 July 2018

Lingling Zu

7

1 reference

9 July 2018

Zhenhua Pan

8

1 reference

9 July 2018

Yuli Wang

9

1 reference

9 July 2018

Yongwen Li

10

1 reference

9 July 2018

Ying Li

11

1 reference

9 July 2018

Min Wang

12

1 reference

9 July 2018

Wang Shen

13

1 reference

9 July 2018

Qinghua Zhou

14

1 reference

9 July 2018

language of work or name

Chinese

0 references

publication date

1 May 2014

1 reference

9 July 2018

Chinese Journal of Lung Cancer

published in

1 reference

9 July 2018

volume

17

1 reference

9 July 2018

issue

5

1 reference

9 July 2018

page(s)

384-390

1 reference

9 July 2018

MiR-494 is regulated by ERK1/2 and modulates TRAIL-induced apoptosis in non-small-cell lung cancer through BIM down-regulation

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6000442

miR-17-5p inhibitor enhances chemosensitivity to gemcitabine via upregulating Bim expression in pancreatic cancer cells

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6000442

Changes of microRNAs-192, 196a and 203 correlate with Barrett's esophagus diagnosis and its progression compared to normal healthy individuals

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6000442

Bim protein degradation contributes to cisplatin resistance

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6000442

MicroRNA-192 targeting retinoblastoma 1 inhibits cell proliferation and induces cell apoptosis in lung cancer cells.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6000442

Overexpression of miR-200c induces chemoresistance in esophageal cancers mediated through activation of the Akt signaling pathway

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6000442

MicroRNA-192 and -215 are upregulated in human gastric cancer in vivo and suppress ALCAM expression in vitro

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6000442

Downregulation of p53-inducible microRNAs 192, 194, and 215 impairs the p53/MDM2 autoregulatory loop in multiple myeloma development

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6000442

miR-192/miR-215 influence 5-fluorouracil resistance through cell cycle-mediated mechanisms complementary to its post-transcriptional thymidilate synthase regulation.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6000442

MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6000442

27 July 2018

Cancer statistics, 2013

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6000442

Bim-targeted cancer therapy: a link between drug action and underlying molecular changes.

12 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6000442

Effects of miR-34a on cell growth and chemoresistance in prostate cancer PC3 cells

12 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6000442

MicroRNA: biogenetic and functional mechanisms and involvements in cell differentiation and cancer

12 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6000442

MicroRNAs as oncogenes and tumor suppressors

12 August 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24854555

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.3779/J.ISSN.1009-3419.2014.05.04

1 reference

9 July 2018

PMCID

6000442

1 reference

9 July 2018

PubMed ID

24854555

1 reference

9 July 2018